Aastrom Biosciences, Inc. to Host Third Quarter 2012 Investor Call on November 8, 2012

Published: Nov 05, 2012

ANN ARBOR, Mich., Nov. 5, 2012 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe, chronic cardiovascular diseases, announces the following webcast:

Back to news